• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素转换酶抑制剂对大鼠离体肾脏血管反应性的降低作用。

Decreased vascular responsiveness produced by angiotensin-converting enzyme inhibitors in the rat isolated kidney.

作者信息

Chiba S, Quilley C P, McGiff J C

出版信息

Hypertension. 1982 May-Jun;4(3 Pt 2):80-5.

PMID:6175573
Abstract

The effects of three angiotensin converting enzyme (ACE) inhibitors - captopril, MK-421 diacid, and teprotide - on renal vascular responses to graded (50, 100, 200 ng) injections of norepinephrine (NE) were examined in rat isolated perfused kidneys, having a mean basal perfusion pressure of 78 +/- 10 mm Hg. The minimum dose of captopril (0.05 microgram/ml, low dose) that abolished the vasoconstrictor responses to 100 and 200 ng angiotensin I did not affect NE-induced renal vasoconstriction, whereas a dose 100 times greater (high-dose captopril, 5 micrograms/ml) reduced the vasoconstrictor action of NE. MK-421 diacid also at high dose (1 microgram/ml), caused similar reduction in renal vasoconstrictor responses to NE. In contrast, a high dose of teprotide (50 micrograms/ml) did not affect renal vascular responsiveness to NE. The threshold dose of NE that released prostaglandins, measured by bioassay, was 50 ng. Indomethacin (1 microgram/ml) prevented NE-induced release of prostaglandins but did not affect the ability of captopril to attenuate NE-induced vasoconstriction. We conclude that captopril and MK-421 diacid decreases vascular reactivity in the rat isolated kidney by a mechanism independent of ACE inhibition and unrelated to a prostaglandin-dependent vascular mechanism. Moreover, the presence of mercapto function in the ACE inhibitor is not essential since captopril, which has a sulfhydryl group, and MK-421 diacid, which lacks this group, have similar effects on renal vascular responsiveness.

摘要

在平均基础灌注压为78±10毫米汞柱的大鼠离体灌注肾脏中,研究了三种血管紧张素转换酶(ACE)抑制剂——卡托普利、MK-421二酸和替普罗肽——对分级(50、100、200纳克)注射去甲肾上腺素(NE)后肾血管反应的影响。消除对100和200纳克血管紧张素I的血管收缩反应的卡托普利最小剂量(0.05微克/毫升,低剂量)不影响NE诱导的肾血管收缩,而剂量大100倍的剂量(高剂量卡托普利,5微克/毫升)则降低了NE的血管收缩作用。MK-421二酸高剂量(1微克/毫升)时也会使对NE的肾血管收缩反应产生类似降低。相比之下,高剂量的替普罗肽(50微克/毫升)不影响肾血管对NE的反应性。通过生物测定法测得的释放前列腺素的NE阈值剂量为50纳克。吲哚美辛(1微克/毫升)可阻止NE诱导的前列腺素释放,但不影响卡托普利减弱NE诱导的血管收缩的能力。我们得出结论,卡托普利和MK-421二酸通过一种独立于ACE抑制且与前列腺素依赖性血管机制无关的机制降低大鼠离体肾脏中的血管反应性。此外,ACE抑制剂中巯基功能并非必需存在,因为具有巯基的卡托普利和缺乏该基团的MK-421二酸对肾血管反应性具有相似的作用。

相似文献

1
Decreased vascular responsiveness produced by angiotensin-converting enzyme inhibitors in the rat isolated kidney.血管紧张素转换酶抑制剂对大鼠离体肾脏血管反应性的降低作用。
Hypertension. 1982 May-Jun;4(3 Pt 2):80-5.
2
Captopril decreases vascular reactivity independently of changes in converting enzyme activity and prostaglandin release in the rat isolated kidney.卡托普利可独立于大鼠离体肾脏中转化酶活性和前列腺素释放的变化而降低血管反应性。
Eur J Pharmacol. 1982 Sep 24;83(3-4):243-52. doi: 10.1016/0014-2999(82)90257-6.
3
Effects of captopril and enalapril on regional vascular resistance and reactivity in spontaneously hypertensive rats.卡托普利和依那普利对自发性高血压大鼠局部血管阻力和反应性的影响。
Hypertension. 1983 May-Jun;5(3):312-20. doi: 10.1161/01.hyp.5.3.312.
4
[Arguments in favor of postsynaptic antagonism by captopril (SQ 14,225) in the perfused kidney].[关于卡托普利(SQ 14,225)在灌注肾中产生突触后拮抗作用的论据]
Arch Mal Coeur Vaiss. 1982 Jun;75 Spec No:51-4.
5
Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.在自发性高血压大鼠和肾性高血压大鼠中,单剂量MK-421和卡托普利的血管紧张素I阻断作用与降压特性之间的关系。
Eur J Pharmacol. 1981 Dec 3;76(2-3):167-76. doi: 10.1016/0014-2999(81)90498-2.
6
Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.N-[(S)-1-羧基-3-苯基丙基]-L-丙氨酰-L-脯氨酸及其乙酯(MK-421)对体外血管紧张素转换酶及体内血管紧张素I升压反应的影响。
J Pharmacol Exp Ther. 1981 Mar;216(3):552-7.
7
Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).转化酶抑制剂马来酸依那普利(MK - 421)的药理特性。
Fed Proc. 1983 Feb;42(2):167-70.
8
Angiotensin-converting enzyme inhibitory activity of SCH 31846, a new non-sulfhydryl inhibitor.新型非巯基抑制剂SCH 31846的血管紧张素转换酶抑制活性
J Cardiovasc Pharmacol. 1983 Jul-Aug;5(4):643-54. doi: 10.1097/00005344-198307000-00021.
9
Effects of angiotensin-converting enzyme inhibitors on the vascular response to norepinephrine.
Am J Cardiol. 1982 Apr 21;49(6):1535-6. doi: 10.1016/0002-9149(82)90380-0.
10
Attenuation of pressor responses to intracerebroventricular angiotensin I by angiotensin converting enzyme inhibitors and their effects on systemic blood pressure in conscious rats.血管紧张素转换酶抑制剂对清醒大鼠脑室内注射血管紧张素I所致升压反应的减弱作用及其对全身血压的影响
Life Sci. 1983 Mar 21;32(12):1297-303. doi: 10.1016/0024-3205(83)90803-2.

引用本文的文献

1
Why are converting enzyme inhibitors vasodilators?为什么转换酶抑制剂是血管扩张剂?
Br J Clin Pharmacol. 1989;28 Suppl 2(Suppl 2):95S-103S; discussion 103S-104S. doi: 10.1111/j.1365-2125.1989.tb03585.x.